Effectiveness of Octreotide in Treating Liver Metastases
Author Information
Author(s): K Pistevou-Gompaki, Nikos Eleftheriadis, Damianos Eleftheriadis, Christos Papaloukas, Apostolos Hatzitolios
Primary Institution: Aristotle’s University of Thessaloniki, Greece
Hypothesis
Is octreotide effective for clinical stabilization in patients with hepatic metastases?
Conclusion
The study suggests that octreotide may be effective in providing pain relief for patients with symptomatic liver metastases.
Supporting Evidence
- 2 out of 7 patients reported excellent improvement in pain after octreotide treatment.
- 4 out of 7 patients experienced some degree of pain relief.
- Side effects were generally mild and manageable.
Takeaway
Doctors used a medicine called octreotide to help patients with liver cancer feel better and have less pain.
Methodology
Patients were treated with octreotide LAR and their pain levels were assessed using visual analogue scale (VAS) and analgesic intake scale (AIS).
Potential Biases
The placebo effect could influence symptom improvement in a significant number of patients.
Limitations
The study lacked a control group and had a diverse range of primary tumors, complicating the evaluation of results.
Participant Demographics
7 patients (3 females, 4 males) aged 63 to 81 years with symptomatic liver metastases.
Statistical Information
P-Value
0.023
Statistical Significance
p = 0.023
Want to read the original?
Access the complete publication on the publisher's website